why choose us

300×250 Ad Slot

Research Article: Internalization of therapeutic antibodies into dendritic cells as a risk factor for immunogenicity

Date Published: 2024-08-28

Abstract:
Introduction: Immunogenicity, the unwanted immune response triggered by therapeutic antibodies, poses significant challenges in biotherapeutic development. This response can lead to the production of anti-drug antibodies, potentially compromising the efficacy and safety of treatments. The internalization of therapeutic antibodies into dendritic cells (DCs) is a critical factor influencing immunogenicity. Using monoclonal antibodies, with differences in non-specific cellular uptake, as tools to explore the impact on the overall risk of immunogenicity, this study explores how internalization influences peptide presentation and subsequently T cell activation.

No summary available.

300×250 Ad Slot